Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
Determine the SP 500 fund with the best 15-year return and understand factors driving the outperformance over this horizon.
28,427 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Alibaba shares slid about 7% after quarterly results, underscoring a push into AI and cloud infrastructure. Investors...
Amazon is pursuing a colossal 2026 investment plan centered on AI and cloud tech. This guide breaks down the risks, p...
A rising AI startup is inviting accredited investors to join a pre-IPO round at $0.85 per share before a March 12 dea...
Retail investors sold NVIDIA, Microsoft, and Oracle to fund SpaceX private rounds, signaling a major shift in how eve...
Bitcoin ETF inflows topped $1 billion over three days, reviving talk of BTC as a market hedge. Traders weigh the sust...
Gold back under $5,000 has traders weighing the next ETF move. This report compares key gold ETFs, costs, and what co...
When a space tech company makes a big fundraising move, its stock can swing just as fast. Learn why intuitive machine...
One large investor dumped 783,379 Truth Social shares, triggering a sharp move in the stock. This article explains wh...
When a streaming giant passes on a blockbuster deal, it sends a clear message about prioritizing value over hype. Thi...
New to prediction markets? This friendly guide shows you how to get started with Myriad, fund your account, and start...